Mabion (272) Stock Overview

Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. Mabion S.A. was founded in 2007 and is based in Konstantynów Lódzki, Poland.

272 Stock Information

Symbol

272

Address

ul. gen. Mariana Langiewicza 60Konstantynów Lódzki, 95-050Poland

Founded

Trading hours

Website

https://www.mabion.eu

Country

🇵🇱 Poland

Phone Number

48 42 207 7890

Mabion (272) Price Chart

Mabion Overview: Key Details and Summary

Stock data	2024	Change
Price	$4.68	N/A
Market Cap	$75.70M	N/A
Shares Outstanding	16.16M	N/A
Employees	248.00	N/A